Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2009

01-10-2009 | Poster presentation

A survey of UK breast surgeons and radiologists to determine current and aspired mammography surveillance practice after treatment for primary breast cancer

Authors: C Robertson, R Thomas, S Heys, A Maxwell, F Gilbert, the Mammographic Surveillance Health Technology Assessment Group

Published in: Breast Cancer Research | Special Issue 2/2009

Login to get access

Excerpt

There is considerable debate about the optimal organisation of a surveillance mammography service following breast cancer treatment in the UK. The optimal frequency and duration of surveillance mammography is unclear, leading to variation in follow-up protocols. The aim of our survey was to describe the variation in current mammography surveillance practice. …
Metadata
Title
A survey of UK breast surgeons and radiologists to determine current and aspired mammography surveillance practice after treatment for primary breast cancer
Authors
C Robertson
R Thomas
S Heys
A Maxwell
F Gilbert
the Mammographic Surveillance Health Technology Assessment Group
Publication date
01-10-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2384

Other articles of this Special Issue 2/2009

Breast Cancer Research 2/2009 Go to the issue

Poster presentation

Is mammogram indicated in patients presenting with breast pain alone in the presence of a normal clinical examination?

Poster presentation

R3 breast lesions - are we categorising and managing them correctly?

Poster presentation

Screen-detected ductal carcinoma in situ - fine needle aspiration versus core biopsy

Poster presentation

Comparison of ultrasound localisation techniques for impalpable breast cancer

Poster presentation

Screen-detected breast cancer: does presence of minimal signs on previous mammograms predict staging/grading of cancer?

Poster presentation

Haematoma-directed ultrasound guidewire localisation of breast lesions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits